Last week, the Mississippi General Assembly overwhelmingly passed HB 1231, which would legalize certain, very limited medical marijuana extracts for patients suffering from seizure disorders. While this bill is a strong endorsement of the medical benefits of marijuana by the Mississippi legislature, it is extremely limited and does not even create a realistic way for patients to obtain the extracts.
The bill, approved by the House 112-6 and the Senate 49-0, now heads to Gov. Phil Bryant, who is expected to sign it. If enacted, it would apply only to patients suffering from epileptic conditions, leaving the vast majority of patients behind. Furthermore, patients would only be able to use marijuana extracts that contain no more than 0.5% THC and more than 15% CBD.
The bill also only allows three specific medical research centers — the National Center for Natural Products Research at the University of Mississippi, the Department of Pharmacy Services at the University of Mississippi Medical Center, and the Mississippi Agricultural and Forestry Experiment Station at Mississippi State University — to produce or possess the marijuana extracts for research. Given that federal law does not allow medical marijuana, it is extremely unlikely that universities will produce marijuana.